Inhaled KMUP-1 prevents allergic pulmonary vascular inflammation and remodeling via no and suppressed MMP-9 and ICAM-1/VCAM-1

Inflammation and Allergy - Drug Targets

Volumn 11, Issue 4, 2012, Pages 251-261

  Liu, Chung Pin ^a   Hsieh, Chung Han ^b   Wu, Bin Nan ^b   Yeh, Jwu Lai ^b   Dai, Zen Kong ^c   Chai, Chee Yin ^c   Chen, Ing Jun ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b YUAN'S GENERAL HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adhesion molecules; Allergen; Cytokines; MMP 9; No donor inhalation; Pulmonary vascular inflammation

Indexed keywords

ALLERGEN; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 3; INTERLEUKIN 5; KMUP 1; N (G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OVALBUMIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; XANTHINE DERIVATIVE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHIAL WALL THICKNESS; CELL COUNT; CONTROLLED STUDY; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG LAVAGE; MOUSE; NEBULIZATION; NONHUMAN; PROTEIN EXPRESSION; PULMONARY VASCULITIS; RESPIRATORY TRACT PARAMETERS; SENSITIZATION; VASCULITIS; WESTERN BLOTTING; ZYMOGRAPHY;

AIRWAY REMODELING; ANIMALS; BRONCHI; CYCLIC GMP-DEPENDENT PROTEIN KINASES; FEMALE; GUANYLATE CYCLASE; HYPERSENSITIVITY; INTERCELLULAR ADHESION MOLECULE-1; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PIPERIDINES; PNEUMONIA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VASCULAR CELL ADHESION MOLECULE-1; XANTHINES;

EID: 84869832877     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152812800958960     Document Type: Article

References (43)

1. Chetta, A.; Zanini, A.; Olivieri, D. Therapeutic approach to vascular remodelling in asthma. Pulm. Pharmacol. Ther., 2007, 20,1-8.
2. Hyvelin, J.M.; Howell, K.; Nichol, A.; Costello, C.M.; Preston, R.J.; McLoughlin, P. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ. Res. 2005, 97, 185-191.
3. de Boer, W.I.; Alagappan, V.K.; Sharma, H.S. Molecular mechanisms in chronic obstructive pulmonary disease, potential targets for therapy. Cell Biochem. Biophys., 2007, 47,131-148.
4. Walsh, G.M. Targeting airway inflammation, novel therapies for the treatment of asthma. Curr. Med. Chem., 2006, 13, 3105-3111.
5. Ricciardolo, F.L.; Sterk, P.J.; Gaston, B.; Folkerts, G. N itric oxide in health and disease of the respiratory system. Physiol. Rev., 2004, 84, 731-765.
6. Ten Broeke, R.; De Crom, R.; Van Haperen, R.; Verweij, V.; Leusink-Muis, T.; Van Ark, I.; De Clerck, F.; Nijkamp, F.P.; Folkerts, G. Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir. Res., 2006, 7, 58.
7. Zhang, F.; Wu, S.; Lu, X.; Wang, M.; Liu, M. Gene transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits. Ann. Thorac. Surg., 2008, 85, 581-585.
8. Okada, S.; Kita, H.; George, T.J.; Gleich, G.J.; Leiferman, K.M. Migration of eosinophils through basement membrane components in vitro, role of matrix metalloproteinase-9. Am. J. Respir. Cell Mol. Biol., 1997, 17, 519-528.
9. Delclaux, C.; Delacourt, C.; D'Ortho, M.P.; Boyer, V.; Lafuma, C.; Harf, A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am. J. Respir. Cell Mol. Biol., 1996, 14, 288-295.
10. Okigami, H.; Takeshita, K.; Tajimi, M.; Komura, H.; Albers, M.; Lehmann, T.E.; Rölle, T.; Bacon, K.B. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4. Eur. J. Pharmacol., 2007, 559, 202-209.
11. Nakamura, S.; Ohtani, H.; Watanabe, Y.; Fukushima, K.; Matsumoto, T.; Kitano, A.; Kobayashi, K.; Nagura, H. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Lab. Invest., 1993, 69, 77-85.
12. Leppert, D.; Waubant, E.; Galardy, R.; Bunnett, N.W.; Hauser, S.L. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol., 1995,154, 4379-4389.
13. Ahn, S.C.; Kim, G.Y.; Kim, J.H.; Baik, S.W.; Han, M.K.; Lee, H.J.; Moon, D.O.; Lee, C.M.; Kang, J.H.; Kim, B.H.; Oh, Y.H.; Park, Y.M. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem. Biophys. Res. Commun., 2004, 313, 148-155.
14. Alp, S.; Skrygan, M.; Schmidt, W.E.; Bastian, A. Sildenafil improves hemodynamic parameters in COPD--an investigation of six patients. Pulm. Pharmacol. Ther., 2006, 19, 386-390.
15. Toward, T.J.; Smith, N.; Broadley, K.J. Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease. Am. J. Respir. Crit. Care Med., 2004,169, 227-234.
16. Wu, B.N.; Chen, C.W.; Liou, S.F.; Yeh, J.L.; Chung, H.H.; Chen, I.J. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4- nitrobenzene) piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea, The involvement of soluble guanylate cyclase and protein kinase G. Mol. Pharmacol., 2006, 70, 977-985.
17. Lin, R.J.; Wu, B.N.; Lo, Y.C.; An, L.M.; Dai, Z.K.; Lin, Y.T.; Tang, C.S.; Chen, I.J. A xanthine-based epithelium-dependent airway relaxant KMUP-3 (7-[2-[4- (4-nitrobenzene) piperazinyl] ethyl]-1,3- dimethylxanthine) increases respiratory performance and protects against tumor necrosis factor-alpha-induced tracheal contraction, involving nitric oxide release and expression of cGMP and protein kinase G. J. Pharmacol. Exp. Ther., 2006, 316, 709-717.
18. Dias-Junior, C.A.; Cau, S.B.; Oliveira, A.M.; Castro, M.M.; Montenegro, M.F.; Gerlach, R.F.; Tanus-Santos, J.E. Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress Thromb. Res.2009,124,349-355.
19. Cataldo, D.D.; Tournoy, K.G.; Vermaelen, K.; Munaut, C.; Foidart, J.M.; Louis, R.; Noël, A.; Pauwels, R.A. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am. J. Pathol., 2002, 61, 491-498.
20. Hibbs, M.S.; Hasty, K.A.; Seyer, J.M.; Kang, A.H.; Mainardi, C.L. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem., 1985, 260, 2493-2500.
21. Grisham, M.B.; Jonhson, G.G.; Lancaster, J.R. Quantification of nitrate and nitrite in extracellular fluids. Methods Enzymol., 1996, 268, 237-246.
22. Tournoy, K.G.; Kips, J.C.; Schou, C.; Pauwels, R.A. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin. Exp. Allergy., 2000, 30, 79-85.
23. Hongo, M.; Ryoke, T.; Schoenfeld, J.; Hunter, J.; Dalton, N.; Clark, R.; Lowe, D.; Chien, K.; Ross, J. Jr. Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy. Basic Res.Cardiol., 2000, 95, 431-441.
24. Elias, J.A.; Lee, C.G.; Zheng, T.; Ma, B.; Homer, R.J.; Zhu, Z. New insights into the pathogenesis of asthma. J. Clin. Invest., 2003, 111, 291-297.
25. Rydell-Törmänen, K.; Uller, L.; Erjefält, J.S. A llergic airway inflammation initiates long-term vascular remodeling of the pulmonary circulation. Int. Arch. Allergy Immunol.,2009,149,251-258.KMUP-1-Asthma andVascular-Resp.doc
26. Roche, W.R.; Beasley, R.; Williams, J.H.; Holgate, S.T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet, 1989, 1 (8637), 520-524.
27. Ricciardolo, F.L.; Sterk, P.J.; Gaston, B.; Folkerts, G.Nitric oxide in health and disease of the respiratory system. Physiol. Rev., 2004, 84, 731-765.
28. Montefort, S.; Holgate, S.T. Adhesion molecules and their role in inflammation. Respir. Med., 1991, 85, 91-99.
29. Montefort, S.; Gratziou, C.; Goulding, D.; Polosa, R.; Haskard, D.O.; Howarth, P.H.; Holgate, S.T.; Carroll, M.P. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest., 1994, 93, 1411-1421.
30. Etienne, S.; Adamson, P.; Greenwood, J.; Strosberg, A.D.; Cazaubon, S.; Couraud, P.O. ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J. Immunol., 1998, 161, 5755-5761.
31. Arita, R.; Hata, Y.; Nakao, S.; Kita, T.; Miura, M.; Kawahara, S.; Zandi, S.; Almulki, L.; Tayyari, F.; Shimokawa, H.; Hafezi-Moghadam, A.; Ishibashi, T. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes, 2009, 58, 215-226.
32. Sauzeau, V.; Le Jeune, H.; Cario-Toumaniantz, C.; Smolenski, A.; Lohmann, S.M.; Bertoglio, J.; Chardin, P.; Pacaud, P.; Loirand, G. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J. Biol. Chem., 2000, 275, 21722-21729.
33. Simpson, J.L.; Scott, R.J.; Boyle, M.J.; Gibson, P.G. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am. J. Respir. Crit. Care Med., 2005, 172, 559-565.
34. Lee, K.S.; Min, K.H.; Kim, S.R.; Park, S.J.; Park, H.S.; Jin, G.Y.; Lee, Y.C. Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma. Am. J. Respir. Crit. Care Med., 2006, 174(2),161-170.
35. McMillan, S.J.; Kearley, J.; Campbell, J.D.; Zhu, X.W.; Larbi, K.Y.; Shipley, J.M.; Senior, R.M.; Nourshargh, S.; Lloyd, C.M. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J. Immunol., 2004, 172, 2586-2594.
36. Dumont, O.; Loufrani, L.; Henrion, D. Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler. Thromb. Vasc. Biol., 2007, 27, 317-324.
37. Gurjar, M.V.; Sharma, R.V.; Bhalla, R.C. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterio. Thromb. Vasc. Biol., 1999, 19, 2871-2877.
38. Li, H.; Mittal, A.; Paul, P.K.; Kumar, M.; Srivastava, D.S.; Tyagi, S.C.; Kumar, A. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase, a potential role of MMP-9 in myopathy. J. Biol. Chem., 2009,284,4439-4450.
39. Nee, L.; O'Connell, S.; Nolan, S.; Ryan, MP.; McMorrow, T. Nitric oxide involvement in TNF-alpha and IL-1 beta-mediated changes in human mesangial cell MMP-9 and TIMP-1. Nephron. Exp. Nephrol., 2008,110, e59-66.
40. Hamada, T.; Duarte, S.; Tsuchihashi, S.; Busuttil, R.W.; Coito, A.J. Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury. Am. J. Pathol., 2009, 174(6), 2265-2277.
41. Crisafulli, C.; Galuppo, M.; Cuzzocrea, S. Effects of genetic and pharmacological inhibition of TNF-alpha in the regulation of inflammation in macrophages. Pharmacol. Res., 2009,60, 332-340.
42. Kobayashi, K.; Nishimura, Y.; Yamashita, T.; Nishiuma, T.; Satouchi, M.; Yokoyama, M. The effect of overexpression of endothelial nitric oxide synthase on eosinophilic lung inflammation in a murine model. Int. Immunopharmacol., 2006, 6(7), 1040-1052.
43. Mukhopadhyay, S.; Xu, F.; Sehgal, P.B. Aberrant cytoplasmic sequestration of eNOS in endothelial cells after monocrotaline, hypoxia, and senescence, live-cell caveolar and cytoplasmic NO imaging. Am. J. Physiol. Heart Circ. Physiol., 2007, 292 (3), H1373-1389.